Vaccine and syringe injection. It use for prevention,immunization and treatment from corona virus infection(novel coronavirus disease 2019,COVID-19,nCoV 2019 from Wuhan). Medicine infectious concept.
After last week’s announcement of a 95% efficiency rate, Pfizer and BioNTech are ready to ask for emergency authorization of its COVID-19 vaccine today.
In a press release, company officials confirmed that the pharmaceutical companies will submit the request to the U.S. Food and Drug Administration (FDA) on Friday.
“Filing for Emergency Use Authorization (EUA) in the U.S. is a critical step in making our vaccine candidate available to the global population as quickly as possible,” said Ugur Sahin, CEO and Co-founder of BioNTech.
At a press briefing Wednesday by Vice President Pence and members of the Coronavirus Task Force, an announcement was made that the vaccine will be able to be distributed 24 hours after the EUA approval.
Chief operating officer of Operation Warp Speed, General Perna, said, “we were going to be able to